Literature DB >> 10673282

High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22.

Z H Arbieva1, K Banerjee, S Y Kim, S L Edassery, V S Maniatis, S K Horrigan, C A Westbrook.   

Abstract

A genomic interval of approximately 1-1.5 Mb centered at the MSR marker on 8p22 has emerged as a possible site for a tumor suppressor gene, based on high rates of allele loss and the presence of a homozygous deletion found in metastatic prostate cancer. The objective of this study was to prepare a bacterial contig of this interval, integrate the contig with radiation hybrid (RH) databases, and use these resources to identify transcription units that might represent the candidate tumor suppressor genes. Here we present a complete bacterial contig across the interval, which was assembled using 22 published and 17 newly originated STSs. The physical map provides twofold or greater coverage over much of the interval, including 17 BACs, 15 P1s, 2 cosmids, and 1 PAC clone. The position of the selected markers across the interval in relation to the other markers on the larger chromosomal scale was confirmed by RH mapping using the Stanford G3 RH panel. Transcribed units within the deletion region were identified by exon amplification, searching of the Human Transcript Map, placement of unmapped expressed sequence tags (ESTs) from the Radiation Hybrid Database (RHdb), and from other published sources, resulting in the isolation of six unique expressed sequences. The transcript map of the deletion interval now includes two known genes (MSR and N33) and six novel ESTs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673282      PMCID: PMC310830          DOI: 10.1101/gr.10.2.244

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  60 in total

1.  Localization of tumor suppressor gene associated with distant metastasis of urinary bladder cancer to a 1-Mb interval on 8p22.

Authors:  K Ohgaki; A Iida; O Ogawa; Y Kubota; M Akimoto; M Emi
Journal:  Genes Chromosomes Cancer       Date:  1999-05       Impact factor: 5.006

2.  Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector.

Authors:  H Shizuya; B Birren; U J Kim; V Mancino; T Slepak; Y Tachiiri; M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

3.  Microsatellite instabilities at five chromosomes in primary breast tumors.

Authors:  U Patel; S Grundfest-Broniatowski; M Gupta; S Banerjee
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

4.  Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas.

Authors:  F Kerangueven; T Noguchi; F Coulier; F Allione; V Wargniez; J Simony-Lafontaine; M Longy; J Jacquemier; H Sobol; F Eisinger; D Birnbaum
Journal:  Cancer Res       Date:  1997-12-15       Impact factor: 12.701

5.  Allelic loss of chromosomal arm 8p in breast cancer progression.

Authors:  R Anbazhagan; H Fujii; E Gabrielson
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

6.  Chromosome 8 Losses in Colorectal Carcinoma: Localization and Correlation With Invasive Disease.

Authors: 
Journal:  Mol Diagn       Date:  1997-03

7.  Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.

Authors:  J M Cunningham; A Shan; M J Wick; S K McDonnell; D J Schaid; D J Tester; J Qian; S Takahashi; R B Jenkins; D G Bostwick; S N Thibodeau
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

8.  A positive selection vector for cloning high molecular weight DNA by the bacteriophage P1 system: improved cloning efficacy.

Authors:  J C Pierce; B Sauer; N Sternberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

9.  Ganglioside GM2 levels in human melanoma cells: inverse correlation with lysosomal beta-hexosaminidase A activity.

Authors:  D S Hoon; M M Kaback; J Lim-Steele; T Tsuchida; D L Morton; R F Irie
Journal:  Biochem Int       Date:  1992-07

10.  Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas.

Authors:  R F Chuaqui; J Sanz-Ortega; C Vocke; W M Linehan; J Sanz-Esponera; Z Zhuang; M R Emmert-Buck; M J Merino
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

View more
  10 in total

1.  DLC1 interaction with α-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activity.

Authors:  Veenu Tripathi; Nicholas C Popescu; Drazen B Zimonjic
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

Review 2.  TUSC3: functional duality of a cancer gene.

Authors:  Kateřina Vašíčková; Peter Horak; Petr Vaňhara
Journal:  Cell Mol Life Sci       Date:  2017-09-19       Impact factor: 9.261

3.  DLC1: a significant GAP in the cancer genome.

Authors:  Aurelia Lahoz; Alan Hall
Journal:  Genes Dev       Date:  2008-07-01       Impact factor: 11.361

4.  UHRF1-KAT7-mediated regulation of TUSC3 expression via histone methylation/acetylation is critical for the proliferation of colon cancer cells.

Authors:  Kenzui Taniue; Tomoatsu Hayashi; Yuki Kamoshida; Akiko Kurimoto; Yasuko Takeda; Lumi Negishi; Kei Iwasaki; Yoshifumi Kawamura; Naoki Goshima; Tetsu Akiyama
Journal:  Oncogene       Date:  2019-10-03       Impact factor: 9.867

5.  Genetic alterations of chromosome 8 genes in oral cancer.

Authors:  Zachary Wei Ern Yong; Zuraiza Mohamad Zaini; Thomas George Kallarakkal; Lee Peng Karen-Ng; Zainal Ariff Abdul Rahman; Siti Mazlipah Ismail; Noor Akmal Sharifah; Wan Mahadzir Wan Mustafa; Mannil Thomas Abraham; Keng Kiong Tay; Rosnah Binti Zain
Journal:  Sci Rep       Date:  2014-08-15       Impact factor: 4.379

6.  Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis.

Authors:  Xiaoqiang Fan; Xiu Zhang; Jie Shen; Haibin Zhao; Xuetao Yu; Yong'an Chen; Zhuonan Zhuang; Xiaolong Deng; Hua Feng; Yunfei Wang; Long Peng
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

7.  TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma.

Authors:  Youji Yan; Zhongjun Chen; Yixiang Liao; Jiajie Zhou
Journal:  Oncol Lett       Date:  2019-03-19       Impact factor: 2.967

Review 8.  The Roles of Tumor-Associated Macrophages in Prostate Cancer.

Authors:  Chenglin Han; Yuxuan Deng; Wenchao Xu; Zhuo Liu; Tao Wang; Shaogang Wang; Jihong Liu; Xiaming Liu
Journal:  J Oncol       Date:  2022-09-07       Impact factor: 4.501

9.  High-resolution array CGH clarifies events occurring on 8p in carcinogenesis.

Authors:  Susanna L Cooke; Jessica C M Pole; Suet-Feung Chin; Ian O Ellis; Carlos Caldas; Paul A W Edwards
Journal:  BMC Cancer       Date:  2008-10-07       Impact factor: 4.430

10.  TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo.

Authors:  Peter Horak; Erwin Tomasich; Petr Vaňhara; Kateřina Kratochvílová; Mariam Anees; Maximilian Marhold; Christof E Lemberger; Marion Gerschpacher; Reinhard Horvat; Maria Sibilia; Dietmar Pils; Michael Krainer
Journal:  Sci Rep       Date:  2014-01-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.